Inventor · disambiguated record
Yunsheng He
Also filed as: HE YUNSHENG
5 granted patents·8 pending applications·3 citations·filing 2005–2024
68Inventor score
Top patents by PatentIndex Score
13 records- 0187US11725246B2Methods of treating ophthalmic disordersNOVARTIS AG·Filed 2020·Granted Aug 15, 2023·2 cites·6 claims
- 0273US12215387B2Biomarker predictive of responsiveness to alpha 7 nicotinic acetylcholine receptor activator treatmentNOVARTIS AG·Filed 2022·Granted Feb 4, 2025·0 cites·20 claims
- 0370US2025129414A1Methods of treating dry eye disease using tnf alpha antagonistsNOVARTIS AG·Filed 2024·Application pending·0 cites
- 0467US9828642B2Biomarkers predictive of responsiveness to alpha 7 nicotinic acetylcholine receptor activator treatmentNOVARTIS AG·Filed 2015·Granted Nov 28, 2017·1 cites·11 claims
- 0562US11359241B2Biomarkers predictive of responsiveness to alpha 7 nicotinic acetylcholine receptor activator treatmentNOVARTIS AG·Filed 2017·Granted Jun 14, 2022·0 cites·8 claims
- 0656US2024197698A1Treatment of acute anxiety with an alpha-7 nicotinic acetylcholine receptor modulatorVANDA PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 0755US12146187B2Methods of treating dry eye disease using TNF alpha antagonistsNOVARTIS AG·Filed 2017·Granted Nov 19, 2024·0 cites·4 claims
- 0849US2023381169A1Treatment of public speaking anxiety with an alpha-7 nicotinic acetylcholine receptor agonistVANDA PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 0947US2010035251A1BioMarkers for the Progression of Alzheimer's DiseaseHE YUNSHENG·Filed 2007·Application pending·0 cites
- 1040US2018230540A1Methods of treating ophthalmic disordersGHOSH JOY·Filed 2016·Application pending·0 cites
- 1138US2009281090A1Biomarkers for the prediction of responsiveness to clozapine treatmentNOVARTIS AG·Filed 2005·Application pending·0 cites
- 1233US2013052644A1Predictive Markers Useful in the Treatment of Fragile X Syndrome (FXS)GOMEZ-MANCILLA BALTAZAR·Filed 2011·Application pending·0 cites
- 1332US2017073754A1Impact of genetic factors on disease progression and response to anti-c5 antibody in geographic atrophyHE YUNSHENG·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Yunsheng He files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →